Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Sorrento Announces Drilling Contract & Receives Permit to Drill Bottom Brook Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Relmada Therapeutics Inc
RLMD
Biotechnology
Drug Manufacturers - Specialty & Generic
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone...
, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:RLMD)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
PressRelease
X
Post by
PressRelease
on May 12, 2025 4:01pm
New Press Release - Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Positive initial Phase 2 proof-of-concept data for NDV-01 at AUA 2025 showing a 90% overall response rate at any time in non-muscle invasive bladder cancer (US prevalence 600K patients)The Phase 2 study for NDV-01 continues with updates at 6, 9 and 12 month data follow-up over the course of 2025....
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 08, 2025 7:30am
New Press Release - Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
CORAL GABLES, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, or “the Company”), a clinical-stage biotechnology company committed to advancing innovative breakthrough therapies, today announced plans to host a conference call and webcast on Monday, May...
read article.
(637)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 29, 2025 11:12am
RE:RLMD....POsitive? Share price don't think so
RLMD trading at 27 pesos this a.m....only down 24.75% Selling paper to The Greater Fools via ATM Next announcement will be a RS ; )
(637)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 28, 2025 4:00pm
RLMD ....ATM financing announcement real soon?
Yep
(637)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 28, 2025 1:53pm
RLMD....U figure it out! Here is the NR
Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025 2025-04-28 10:39 ET - News Release 90% of patients
...more
(637)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 28, 2025 1:50pm
RLMD....POsitive? Share price don't think so
Just sayin ....32 pesos now ....LoL
(637)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 28, 2025 1:44pm
RLMD.... What's that sound u ask ?
Shareholders bailing out open windows
(6)
•••
10QKing
X
Post by
10QKing
on Dec 04, 2024 8:28am
RLMD 2$+ Cash per Share Trading at 70 CENTS Down Huge should
RLMD Should move back closer to a 1$
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Team Spotlight: Every discovery begins with the people behind it
Sorrento Resources Announces Drilling Contract and Receives Permit to Drill Bottom Brook Project
Sranan Gold Reports 11 M Grading 7.33 g/t Gold Including 4 M at 14.59 g/t Gold
Global Currency Shifts Are Reshaping Commodities. Learn How. Secure Your Seat at VRIC 2026
Pinnacle Provides Progress Update for El Potrero Gold-Silver Project
Allied Critical Metals Announces Receipt of Environmental Permit for the Borralha Tungsten Project in Portugal
Podcasts